The Umesh Modi Group has reportedly sought a valuation of up to ₹4,000 crore for the pharmaceutical firm as it looks to offload a minority stake to private equity investors.
Betadine maker Win-Medicare eyes $150-200 million stake sale; taps EY
Related Posts
DMart’s first quarter results will evaluate investor confidence regarding the company’s CEO succession strategy.
**Avenue Supermarts Faces Key Test in Q1FY26 Amid Leadership Transition** Avenue Supermarts Ltd, the operator of the DMart retail chain,…
Indian automobile dealers are exercising caution regarding June sales due to restrictions on rare earth materials and an excess of inventory.
**Indian Auto Dealers Anticipate Cautious Demand Amid Supply Challenges** As June approaches, Indian auto dealers are bracing for a cautious…
Mozambique is close to finalizing an agreement to restart its $20 billion gas development project led by Total.
**Mozambique’s President Optimistic About TotalEnergies Gas Project Restart** Mozambican President Daniel Chapo has expressed optimism about concluding negotiations with TotalEnergies…
